推进! 推进! 推进! 推进! 推进! :随机对照试验,以减少1型糖尿病青少年的糖尿病困扰
Sarah S Jaser1, Karishma Datye1, James C Slaughter1
1Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
概括
积极心理学干预没有显著影响1型糖尿病青少年的糖尿病困扰或HbA1c. 然而,干预组和对照组在12个月内显示糖尿病患病率有所降低.
科学领域:
- 青少年健康 青少年健康
- 内分泌学 在内分泌学.
- 心理学 心理学 心理学
背景情况:
- 青少年1型糖尿病 (T1D) 管理存在独特的挑战,包括糖尿病困扰 (DD).
- 需要有效的干预措施来改善这一群体的心理社会福祉和血糖控制.
研究的目的:
- 评估通过短信传递的积极心理干预对T1D青少年糖尿病困扰和HbA1c水平的影响.
- 为了比较糖尿病教育+积极影响干预与增强的常规护理 (仅糖尿病教育).
主要方法:
- 一项随机对照试验,涉及198名青少年-护理人员二位 (年龄13-17岁) 具有较高的DD.
- 参与者被分配到增强的常规护理或接受自动化短信的干预组.
- 主要结局包括12个月的糖尿病痛苦和HbA1c的变化.
主要成果:
- 观察到高参与度,有91%的消息响应和90%的保留时间超过12个月.
- 两组都报告了糖尿病痛苦的减少;参与者更有可能进入正常范围,而不是增加痛苦.
- 干预组和对照组之间没有发现DD或HbA1c的显著差异,尽管HbA1c保持稳定.
结论:
- 与标准护理相比,积极心理学干预并没有显著改善糖尿病困扰或HbA1c.
- 两支手臂中的青少年都经历了减少糖尿病困扰的情况,这表明参与和支持的总体好处.
- 需要进一步的研究,以确定最佳的,引人入胜的和低负担的干预措施,为痛苦的青少年T1D.
相关概念视频
01:22Diabetes Mellitus: Overview and Type I Subtype
3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
01:15Diabetes: Management and Pharmacotherapy
402
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
402
01:16Insulin: Dosing Regimen and Adverse Effects
263
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
263
01:22Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
01:15Diabetes: Symptoms, Diagnosis, and Complications
697
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
697
01:16Hormones Regulating Blood Glucose
4.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
4.1K